Home Contact Us Careers Japanese
Novacor® LVASLevacor VADNovacor II LVASHome
About WorldHeart About Heart Failure Products Patients Events Investor Relations
 
 

Products

Send

Novacor® LVAS

WorldHeart's Novacor® LVAS is an implanted, wearable system that provides pulsatile circulatory support for patients with life-threatening heart failure. Novacor® LVAS has been implanted in more than 1,700 patients, and is the first mechanical circulatory support device to support a single patient for more than six years.

Unmatched Reliability

In the nearly 100 medical centers worldwide that use Novacor® LVAS, it is renowned for its reliability, durability and predictability of wear. Of the more than 1,700 Novacor® LVAS recipients to date, 172 primarily Bridge-to-Transplant patients have been supported by Novacor® LVAS for more than one year. Among these recipients, 45 have been supported for more than two years, 24 for more than three years, 11 for more than four years and 1 for more than six years. Only 1.4% of the pumps have needed replacement. No patient deaths have been attributed to Novacor® LVAS failure.

Please browse this section for information about How Novacor® LVAS Works, Patient Experiences and recent Product Enhancements that are now available.


AVAILABILITY

WorldHeart's Novacor® LVAS is approved for use in North America, the European Union and Japan.

"); //-->